Ontology highlight
ABSTRACT:
SUBMITTER: Nakagawa Y
PROVIDER: S-EPMC4414156 | biostudies-literature | 2015 Feb
REPOSITORIES: biostudies-literature
Nakagawa Yuko Y Sedukhina Anna S AS Okamoto Naoki N Nagasawa Satoi S Suzuki Nao N Ohta Tomohiko T Hattori Hiroyoshi H Roche-Molina Marta M Narváez Ana J AJ Jeyasekharan Anand D AD Bernal Juan A JA Sato Ko K
Oncotarget 20150201 6
PARP inhibitors are a class of promising anti-cancer drugs, with proven activity in BRCA mutant cancers. However, as with other targeted agents, treatment with PARP inhibitors generates acquired resistance within these tumors. The mechanism of this acquired resistance is poorly understood. We established cell lines that are resistant to PARP inhibitor by continuous treatment with the drug, and then used RNA sequencing to compare gene expression. Pathway analysis on the RNA sequencing data indica ...[more]